News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
News
Business
MEDICREA: 2012 Annual Sales
January 16, 2013
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
The MEDICREA Group (FR0004178572-ALMED), a company specialized in the development of innovative surgical technologies for the treatment of spinal pathologies, listed on Alternext by NYSE - Euronext Paris, announces its 2012 annual sales.
Twitter
LinkedIn
Facebook
Email
Print
Earnings
Europe
MORE ON THIS TOPIC
Earnings
Merck Cuts $3B to Support Aggressive Launch Schedule, Late-Stage R&D
July 29, 2025
·
3 min read
·
Annalee Armstrong
C-suite
Novo Nordisk Names New Leader, Cuts 2025 Sales Guidance By 5%
July 29, 2025
·
2 min read
·
Heather McKenzie
Layoff Tracker
Adaptimmune Expects To Cut 62% of Staff After Cell Therapy Asset Sale
July 29, 2025
·
170 min read
·
BioSpace Editorial Staff
Startups
BMS, Bain Birth Biotech for Autoimmune Disorders
July 29, 2025
·
2 min read
·
Tristan Manalac
